| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 4.70e-05 | 83 | 48 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.16e-05 | 85 | 48 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | RNA polymerase I core promoter sequence-specific DNA binding | 3.07e-04 | 11 | 48 | 2 | GO:0001164 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 3.13e-04 | 55 | 48 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.44e-04 | 739 | 48 | 8 | GO:0003682 | |
| GeneOntologyMolecularFunction | transcription factor binding | 3.90e-04 | 753 | 48 | 8 | GO:0008134 | |
| GeneOntologyMolecularFunction | RNA polymerase I transcription regulatory region sequence-specific DNA binding | 4.34e-04 | 13 | 48 | 2 | GO:0001163 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.68e-04 | 417 | 48 | 6 | GO:0061629 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 5.36e-04 | 66 | 48 | 3 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 5.36e-04 | 66 | 48 | 3 | GO:0001098 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.05e-03 | 187 | 48 | 4 | GO:0016922 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 1.64e-03 | 25 | 48 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 1.91e-03 | 27 | 48 | 2 | GO:0001091 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2.12e-03 | 1459 | 48 | 10 | GO:0000977 | |
| GeneOntologyMolecularFunction | lysine-acetylated histone binding | 2.36e-03 | 30 | 48 | 2 | GO:0070577 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 2.52e-03 | 31 | 48 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 2.54e-03 | 1244 | 48 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 2.59e-03 | 582 | 48 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 2.85e-03 | 33 | 48 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.93e-03 | 1271 | 48 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.57e-03 | 37 | 48 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | helicase activity | 6.48e-03 | 158 | 48 | 3 | GO:0004386 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor activity | 6.95e-03 | 52 | 48 | 2 | GO:0016251 | |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 2.51e-12 | 36 | 50 | 7 | GO:0035459 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.07e-07 | 159 | 50 | 7 | GO:0006888 | |
| GeneOntologyBiologicalProcess | triglyceride homeostasis | 6.48e-06 | 50 | 50 | 4 | GO:0070328 | |
| GeneOntologyBiologicalProcess | acylglycerol homeostasis | 7.02e-06 | 51 | 50 | 4 | GO:0055090 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | 1.66e-05 | 339 | 50 | 7 | GO:0048193 | |
| GeneOntologyBiologicalProcess | protein secretion | 1.85e-05 | 480 | 50 | 8 | GO:0009306 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | 1.93e-05 | 483 | 50 | 8 | GO:0035592 | |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | 2.14e-05 | 490 | 50 | 8 | GO:0071692 | |
| GeneOntologyBiologicalProcess | response to progesterone | 1.77e-04 | 45 | 50 | 3 | GO:0032570 | |
| GeneOntologyBiologicalProcess | secretion by cell | CACNA1A CTAGE9 MIA2 CTAGE1 CTAGE8 SREBF1 CTAGE15 CHD7 CTAGE6 CTAGE4 | 1.99e-04 | 1064 | 50 | 10 | GO:0032940 |
| GeneOntologyBiologicalProcess | cholesterol homeostasis | 2.31e-04 | 124 | 50 | 4 | GO:0042632 | |
| GeneOntologyBiologicalProcess | sterol homeostasis | 2.39e-04 | 125 | 50 | 4 | GO:0055092 | |
| GeneOntologyBiologicalProcess | developmental growth | 3.01e-04 | 911 | 50 | 9 | GO:0048589 | |
| GeneOntologyBiologicalProcess | RNA polymerase I preinitiation complex assembly | 3.12e-04 | 11 | 50 | 2 | GO:0001188 | |
| GeneOntologyBiologicalProcess | mRNA transcription | 3.58e-04 | 57 | 50 | 3 | GO:0009299 | |
| GeneOntologyBiologicalProcess | export from cell | CACNA1A CTAGE9 MIA2 CTAGE1 CTAGE8 SREBF1 CTAGE15 CHD7 CTAGE6 CTAGE4 | 3.80e-04 | 1153 | 50 | 10 | GO:0140352 |
| GeneOntologyBiologicalProcess | central nervous system development | CACNA1A SEMA3F NDNF TENM4 DBX1 GLI1 SMARCA4 CHD7 PRKDC MEIS2 | 5.10e-04 | 1197 | 50 | 10 | GO:0007417 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 8.47e-12 | 42 | 51 | 7 | GO:0070971 | |
| GeneOntologyCellularComponent | chromatin | WBP2 CDK2AP2 DBX1 SREBF1 SMARCA4 IST1 CHD7 DLX6 PRKDC TAF1L MEIS2 SMAD5 TBP | 4.00e-05 | 1480 | 51 | 13 | GO:0000785 |
| MousePheno | decreased circulating VLDL triglyceride level | 2.16e-07 | 19 | 40 | 4 | MP:0003976 | |
| MousePheno | decreased triglyceride level | 5.12e-05 | 348 | 40 | 7 | MP:0005318 | |
| MousePheno | abnormal triglyceride level | 6.30e-05 | 639 | 40 | 9 | MP:0000187 | |
| MousePheno | abnormal habenula morphology | 7.94e-05 | 5 | 40 | 2 | MP:0004082 | |
| MousePheno | abnormal circulating triglyceride level | 8.84e-05 | 516 | 40 | 8 | MP:0011969 | |
| MousePheno | decreased circulating triglyceride level | 1.20e-04 | 275 | 40 | 6 | MP:0002644 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | SM00592 | |
| Domain | BRK_domain | 8.46e-05 | 6 | 45 | 2 | IPR006576 | |
| Domain | BRK | 8.46e-05 | 6 | 45 | 2 | PF07533 | |
| Domain | GRAM | 1.27e-03 | 22 | 45 | 2 | PF02893 | |
| Domain | GRAM | 1.27e-03 | 22 | 45 | 2 | IPR004182 | |
| Domain | Bromodomain_CS | 1.78e-03 | 26 | 45 | 2 | IPR018359 | |
| Domain | Helicase_C | 2.18e-03 | 107 | 45 | 3 | PF00271 | |
| Domain | HELICc | 2.18e-03 | 107 | 45 | 3 | SM00490 | |
| Domain | Helicase_C | 2.24e-03 | 108 | 45 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 2.30e-03 | 109 | 45 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 2.30e-03 | 109 | 45 | 3 | PS51192 | |
| Domain | DEXDc | 2.30e-03 | 109 | 45 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 2.36e-03 | 110 | 45 | 3 | IPR014001 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | IPR000330 | |
| Domain | SNF2_N | 2.69e-03 | 32 | 45 | 2 | PF00176 | |
| Domain | BROMODOMAIN_1 | 3.58e-03 | 37 | 45 | 2 | PS00633 | |
| Domain | Bromodomain | 3.78e-03 | 38 | 45 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.38e-03 | 41 | 45 | 2 | PS50014 | |
| Domain | BROMO | 4.60e-03 | 42 | 45 | 2 | SM00297 | |
| Domain | Bromodomain | 4.60e-03 | 42 | 45 | 2 | IPR001487 | |
| Domain | - | 4.60e-03 | 42 | 45 | 2 | 1.20.920.10 | |
| Pathway | REACTOME_CARGO_CONCENTRATION_IN_THE_ER | 9.36e-07 | 36 | 30 | 4 | MM15300 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.95e-04 | 10 | 30 | 2 | MM1532 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 2.85e-04 | 12 | 30 | 2 | M22006 | |
| Pubmed | Mea6 controls VLDL transport through the coordinated regulation of COPII assembly. | 4.10e-12 | 4 | 51 | 4 | 27311593 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 31244610 | ||
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 21807889 | ||
| Pubmed | Deletion of Mea6 in Cerebellar Granule Cells Impairs Synaptic Development and Motor Performance. | 4.10e-12 | 4 | 51 | 4 | 33718348 | |
| Pubmed | 4.10e-12 | 4 | 51 | 4 | 12586826 | ||
| Pubmed | cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. | 2.05e-11 | 5 | 51 | 4 | 12839582 | |
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 18630941 | ||
| Pubmed | 2.05e-11 | 5 | 51 | 4 | 19131326 | ||
| Pubmed | Characterization and expression pattern of the novel MIA homolog TANGO. | 2.05e-11 | 5 | 51 | 4 | 15183315 | |
| Pubmed | Mea6/cTAGE5 cooperates with TRAPPC12 to regulate PTN secretion and white matter development. | 2.05e-11 | 5 | 51 | 4 | 38439956 | |
| Pubmed | A tissue-specific atlas of mouse protein phosphorylation and expression. | 2.05e-11 | 5 | 51 | 4 | 21183079 | |
| Pubmed | cTAGE5 deletion in pancreatic β cells impairs proinsulin trafficking and insulin biogenesis in mice. | 1.43e-10 | 7 | 51 | 4 | 29133483 | |
| Pubmed | Misexpression of MIA disrupts lung morphogenesis and causes neonatal death. | 5.14e-10 | 9 | 51 | 4 | 18342301 | |
| Pubmed | Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice. | 2.90e-09 | 13 | 51 | 4 | 11839810 | |
| Pubmed | cTAGE5/MEA6 plays a critical role in neuronal cellular components trafficking and brain development. | 5.53e-09 | 15 | 51 | 4 | 30224460 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 8.19e-09 | 283 | 51 | 8 | 30585729 | |
| Pubmed | 5.92e-08 | 6 | 51 | 3 | 17011493 | ||
| Pubmed | 9.62e-08 | 549 | 51 | 9 | 38280479 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | UBAP2 ZC3H4 YLPM1 SMARCA4 RPRD2 CHD7 DLX6 PRKDC TAF1L PRRC2A DDX5 | 1.09e-07 | 954 | 51 | 11 | 36373674 |
| Pubmed | 2.33e-07 | 36 | 51 | 4 | 33230114 | ||
| Pubmed | The phagosomal proteome in interferon-gamma-activated macrophages. | 3.60e-07 | 40 | 51 | 4 | 19144319 | |
| Pubmed | 8.50e-07 | 220 | 51 | 6 | 24550385 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SYNRG UBAP2 ZC3H4 YLPM1 SMARCA4 IST1 RPRD2 PRKDC PRRC2A DDX5 | 8.76e-07 | 934 | 51 | 10 | 33916271 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.69e-06 | 774 | 51 | 9 | 15302935 | |
| Pubmed | Brg1 regulates pro-lipogenic transcription by modulating SREBP activity in hepatocytes. | 2.11e-06 | 2 | 51 | 2 | 29857051 | |
| Pubmed | Serological detection of cutaneous T-cell lymphoma-associated antigens. | 2.39e-06 | 18 | 51 | 3 | 11149944 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 3.05e-06 | 430 | 51 | 7 | 35044719 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.18e-06 | 154 | 51 | 5 | 16055720 | |
| Pubmed | 5.15e-06 | 23 | 51 | 3 | 16672333 | ||
| Pubmed | KMT2C UBAP2 YLPM1 SMARCA4 RPRD2 CHD7 DLX6 TAF1L PRRC2A SMAD5 TBP | 5.68e-06 | 1429 | 51 | 11 | 35140242 | |
| Pubmed | Expansion, in vivo-ex vivo cycling, and genetic manipulation of primary human hepatocytes. | 6.32e-06 | 3 | 51 | 2 | 31915293 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 15900494 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16822332 | ||
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 12217962 | ||
| Pubmed | Lhx2 links the intrinsic and extrinsic factors that control optic cup formation. | 1.06e-05 | 29 | 51 | 3 | 19906857 | |
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 23184344 | ||
| Pubmed | 1.26e-05 | 4 | 51 | 2 | 10187805 | ||
| Pubmed | Constitutive expression of the brg1 gene requires GC-boxes near to the transcriptional start site. | 1.26e-05 | 4 | 51 | 2 | 21149256 | |
| Pubmed | A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. | 1.28e-05 | 205 | 51 | 5 | 12040188 | |
| Pubmed | 1.30e-05 | 31 | 51 | 3 | 36445780 | ||
| Pubmed | 2.00e-05 | 225 | 51 | 5 | 12168954 | ||
| Pubmed | Gli1 marks a sentinel muscle stem cell population for muscle regeneration. | 2.10e-05 | 5 | 51 | 2 | 37914731 | |
| Pubmed | 2.56e-05 | 399 | 51 | 6 | 35987950 | ||
| Pubmed | 2.78e-05 | 118 | 51 | 4 | 21078624 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 3.02e-05 | 411 | 51 | 6 | 35182466 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 10601022 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 16389595 | ||
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 28576771 | ||
| Pubmed | MIA2 CTAGE1 CNTRL CTAGE8 YLPM1 CTAGE15 CTAGE6 PRKDC CTAGE4 DDX5 | 3.93e-05 | 1442 | 51 | 10 | 35575683 | |
| Pubmed | 4.06e-05 | 130 | 51 | 4 | 19386638 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 14756671 | ||
| Pubmed | 4.41e-05 | 7 | 51 | 2 | 17074803 | ||
| Pubmed | 4.57e-05 | 134 | 51 | 4 | 19030180 | ||
| Pubmed | 4.60e-05 | 268 | 51 | 5 | 33640491 | ||
| Pubmed | RNF12 catalyzes BRF1 ubiquitination and regulates RNA polymerase III-dependent transcription. | 5.55e-05 | 50 | 51 | 3 | 30413534 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 11358480 | ||
| Pubmed | CHD7 cooperates with PBAF to control multipotent neural crest formation. | 5.87e-05 | 8 | 51 | 2 | 20130577 | |
| Pubmed | 5.87e-05 | 8 | 51 | 2 | 10224267 | ||
| Pubmed | Analysis of HIV-1 Gag protein interactions via biotin ligase tagging. | 6.99e-05 | 54 | 51 | 3 | 25631074 | |
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 12665565 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 26305926 | ||
| Pubmed | 7.54e-05 | 9 | 51 | 2 | 19934017 | ||
| Pubmed | Ikaros interacts with P-TEFb and cooperates with GATA-1 to enhance transcription elongation. | 7.54e-05 | 9 | 51 | 2 | 21245044 | |
| Pubmed | Bone marrow endosteal stem cells dictate active osteogenesis and aggressive tumorigenesis. | 7.54e-05 | 9 | 51 | 2 | 37185464 | |
| Pubmed | The genetic aetiology of late-onset chronic progressive cerebellar ataxia. A population-based study. | 9.42e-05 | 10 | 51 | 2 | 19259763 | |
| Pubmed | A role of DNA-PK for the metabolic gene regulation in response to insulin. | 9.42e-05 | 10 | 51 | 2 | 19303849 | |
| Pubmed | Screening for premutation in the FMR1 gene in male patients suspected of spinocerebellar ataxia. | 9.42e-05 | 10 | 51 | 2 | 19235102 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 9.88e-05 | 1294 | 51 | 9 | 30804502 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 1.07e-04 | 167 | 51 | 4 | 20362541 | |
| Pubmed | 1.11e-04 | 63 | 51 | 3 | 37052853 | ||
| Pubmed | 1.15e-04 | 11 | 51 | 2 | 20333701 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 15140983 | ||
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 31767679 | ||
| Pubmed | Developmental origin of the neuronal subtypes that comprise the amygdalar fear circuit in the mouse. | 1.38e-04 | 12 | 51 | 2 | 20484636 | |
| Pubmed | Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. | 1.38e-04 | 12 | 51 | 2 | 15749018 | |
| Pubmed | 1.38e-04 | 12 | 51 | 2 | 10021349 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.43e-04 | 180 | 51 | 4 | 35198878 | |
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 1.63e-04 | 13 | 51 | 2 | 11557891 | |
| Pubmed | Indian hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. | 1.63e-04 | 13 | 51 | 2 | 18434416 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 34557486 | ||
| Pubmed | Sox2-Evf2 lncRNA-mediated mechanisms of chromosome topological control in developing forebrain. | 1.63e-04 | 13 | 51 | 2 | 33593819 | |
| Pubmed | 1.63e-04 | 13 | 51 | 2 | 23319608 | ||
| Pubmed | 1.80e-04 | 191 | 51 | 4 | 24146773 | ||
| Pubmed | A mouse model for Meckel syndrome reveals Mks1 is required for ciliogenesis and Hedgehog signaling. | 1.90e-04 | 14 | 51 | 2 | 19776033 | |
| Pubmed | Cytoneme signaling provides essential contributions to mammalian tissue patterning. | 1.90e-04 | 14 | 51 | 2 | 38171360 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 23028455 | ||
| Pubmed | Lrp4 modulates extracellular integration of cell signaling pathways in development. | 1.90e-04 | 14 | 51 | 2 | 19116665 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 32156750 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 1.90e-04 | 14 | 51 | 2 | 36289231 | |
| Pubmed | Roles of Bmp4 during tooth morphogenesis and sequential tooth formation. | 1.90e-04 | 14 | 51 | 2 | 23250216 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 21664576 | ||
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 33305180 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 23785148 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 19709628 | ||
| Pubmed | Arx Expression Suppresses Ventralization of the Developing Dorsal Forebrain. | 2.19e-04 | 15 | 51 | 2 | 30659230 | |
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 14701856 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 25458012 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 18548003 | ||
| Pubmed | 2.19e-04 | 15 | 51 | 2 | 14580349 | ||
| Pubmed | Lrp4/Wise regulates palatal rugae development through Turing-type reaction-diffusion mechanisms. | 2.19e-04 | 15 | 51 | 2 | 30235284 | |
| Interaction | CTAGE1 interactions | 3.56e-14 | 10 | 50 | 6 | int:CTAGE1 | |
| Interaction | CTAGE4 interactions | 1.44e-08 | 3 | 50 | 3 | int:CTAGE4 | |
| Interaction | CTAGE15 interactions | 1.43e-07 | 5 | 50 | 3 | int:CTAGE15 | |
| Interaction | CTAGE6 interactions | 2.86e-07 | 6 | 50 | 3 | int:CTAGE6 | |
| Interaction | CTAGE8 interactions | 2.86e-07 | 6 | 50 | 3 | int:CTAGE8 | |
| Interaction | MIA2 interactions | 3.53e-07 | 113 | 50 | 6 | int:MIA2 | |
| Interaction | YAP1 interactions | WBP2 KMT2C CDIP1 UBAP2 GLI1 YLPM1 SMARCA4 RPRD2 PRKDC PRRC2A DDX5 SMAD5 | 1.11e-05 | 1095 | 50 | 12 | int:YAP1 |
| Interaction | MIA3 interactions | 2.22e-05 | 231 | 50 | 6 | int:MIA3 | |
| Interaction | ZCCHC2 interactions | 2.46e-05 | 23 | 50 | 3 | int:ZCCHC2 | |
| Interaction | AR interactions | KMT2C ZC3H4 YLPM1 SREBF1 SMARCA4 RPRD2 CHD7 PRKDC ITPRID2 DDX5 TBP | 2.48e-05 | 992 | 50 | 11 | int:AR |
| Interaction | SMC5 interactions | UBAP2 ZC3H4 YLPM1 SMARCA4 RPRD2 CHD7 DLX6 PRKDC TAF1L PRRC2A DDX5 | 2.67e-05 | 1000 | 50 | 11 | int:SMC5 |
| Interaction | SOX7 interactions | 5.08e-05 | 82 | 50 | 4 | int:SOX7 | |
| Interaction | CREM interactions | 7.32e-05 | 90 | 50 | 4 | int:CREM | |
| Interaction | CTAGE7P interactions | 8.99e-05 | 6 | 50 | 2 | int:CTAGE7P | |
| Interaction | SP7 interactions | 1.02e-04 | 304 | 50 | 6 | int:SP7 | |
| Interaction | NAA40 interactions | SYNRG UBAP2 ZC3H4 YLPM1 SMARCA4 IST1 RPRD2 PRKDC PRRC2A DDX5 | 1.21e-04 | 978 | 50 | 10 | int:NAA40 |
| Interaction | WWP2 interactions | 1.96e-04 | 840 | 50 | 9 | int:WWP2 | |
| Interaction | ERG interactions | 2.24e-04 | 223 | 50 | 5 | int:ERG | |
| Interaction | SP1 interactions | 2.75e-04 | 365 | 50 | 6 | int:SP1 | |
| Interaction | PAX6 interactions | 2.79e-04 | 366 | 50 | 6 | int:PAX6 | |
| Interaction | UQCR11 interactions | 3.08e-04 | 53 | 50 | 3 | int:UQCR11 | |
| Interaction | SAA1 interactions | 3.26e-04 | 54 | 50 | 3 | int:SAA1 | |
| Interaction | POLR2A interactions | 3.36e-04 | 536 | 50 | 7 | int:POLR2A | |
| Interaction | MAPKAPK2 interactions | 3.40e-04 | 134 | 50 | 4 | int:MAPKAPK2 | |
| Interaction | MTNR1B interactions | 3.49e-04 | 135 | 50 | 4 | int:MTNR1B | |
| Interaction | SMAD2 interactions | 3.65e-04 | 385 | 50 | 6 | int:SMAD2 | |
| Cytoband | 7q35 | 4.61e-09 | 55 | 51 | 5 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 9.25e-07 | 66 | 51 | 4 | chr7q35 | |
| GeneFamily | CTAGE family | 1.71e-16 | 15 | 32 | 7 | 907 | |
| GeneFamily | WD repeat domain containing|GRAM domain containing|BEACH domain containing | 2.34e-04 | 13 | 32 | 2 | 1146 | |
| GeneFamily | NKL subclass homeoboxes and pseudogenes | 6.25e-03 | 67 | 32 | 2 | 519 | |
| Coexpression | TERAO_AOX4_TARGETS_HG_UP | 4.39e-07 | 32 | 51 | 4 | MM922 | |
| Coexpression | BRACHAT_RESPONSE_TO_METHOTREXATE_DN | 8.94e-07 | 38 | 51 | 4 | MM1161 | |
| Coexpression | BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN | 3.74e-06 | 54 | 51 | 4 | MM1195 | |
| Coexpression | GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP | 2.63e-05 | 180 | 51 | 5 | M357 | |
| Coexpression | PLASARI_TGFB1_TARGETS_1HR_DN | 3.70e-05 | 5 | 51 | 2 | M2444 | |
| Coexpression | PLASARI_TGFB1_TARGETS_1HR_DN | 3.70e-05 | 5 | 51 | 2 | MM943 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.28e-06 | 200 | 51 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.99e-06 | 197 | 49 | 6 | 4266_DN | |
| Disease | liver cirrhosis (implicated_via_orthology) | 1.76e-04 | 13 | 45 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 3.29e-04 | 616 | 45 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.29e-04 | 616 | 45 | 6 | C0376358 | |
| Disease | stomach carcinoma (is_marker_for) | 6.14e-04 | 24 | 45 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Sezary Syndrome | 7.79e-04 | 27 | 45 | 2 | C0036920 | |
| Disease | age at first birth measurement | 8.22e-04 | 120 | 45 | 3 | EFO_0009101 | |
| Disease | age at menopause | 1.15e-03 | 302 | 45 | 4 | EFO_0004704 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDGPKPMPPYSSMFI | 1211 | O00555 | |
| FIPPHMSADGTYMPP | 66 | Q9H305 | |
| MSADGTYMPPGFYPP | 71 | Q9H305 | |
| PPGYMMYTVLPDGSP | 1241 | Q7Z7A1 | |
| DYRMMFPPPGQSYPD | 571 | Q96RT6 | |
| RMMFPPPGQSYPDST | 606 | Q8IX94 | |
| KMMFPPPGQSYPDSA | 606 | Q86UF2 | |
| RMMFPPPGQSYPDST | 606 | P0CG41 | |
| RMMFPPPGQSYPDST | 606 | A4FU28 | |
| KMMFPPPGQSYPDSA | 606 | A4D2H0 | |
| PQGTYASPPPMSPMK | 386 | Q9P2D1 | |
| ASAKGVSMPPNSYMP | 141 | P56179 | |
| PKPGPMAYADSMENF | 66 | O95156 | |
| PPSPMDPYAKMVGTP | 1891 | Q8NEZ4 | |
| GPMGMSMAQPSYTPP | 396 | O14770 | |
| SAPPMDGSPGKYMSH | 186 | Q76MJ5 | |
| PATAAAPMIGYPMPT | 596 | P17844 | |
| SSYMEMKGPPSGSPP | 941 | Q5VY43 | |
| MMFPGLLAPPAGYPS | 1 | A6NMT0 | |
| AFMMAPKPGLDFSPF | 236 | Q8TB73 | |
| MFNSMTPPPISSYGE | 1 | P08151 | |
| PGFMPSPTFDMAQLY | 136 | Q9UHC3 | |
| HMTKDMFPGPYPRTP | 31 | O95169 | |
| PMMRGPDPAAAPYST | 931 | P28290 | |
| MFPMGTPDPEYPADA | 226 | P09923 | |
| FGPPSMGYVQAMKPP | 51 | O75956 | |
| PSKPGFPDEPMREYM | 41 | Q0P5P2 | |
| PMPMPMPSANTPFSY | 231 | P53990 | |
| MPEPKFMYGSHYSSP | 381 | Q92636 | |
| PMGQMKPDDSKPPVY | 176 | P16930 | |
| FEYSGPPPSAMMNLE | 836 | Q5VT52 | |
| MMDYPYPTDFLGPLP | 271 | Q9UHL4 | |
| RRMMFPPPGQSYPDS | 1211 | Q96PC5 | |
| QWMPFSGKMPYPRPG | 396 | Q13275 | |
| FLGMRPPGPQYTPDM | 101 | Q9UMZ2 | |
| SMDPGYPKMIAHDFP | 406 | P03956 | |
| MTPGPYTSQPPDMYD | 1656 | Q8IZX4 | |
| PQFPPYRGMMPPFMY | 241 | P48634 | |
| MGPPPSPMDQHSQGY | 106 | P51532 | |
| DFGYVPNPKMPNTFM | 346 | Q9HAT2 | |
| TPPPAYMPPDDQMGQ | 221 | Q99717 | |
| QPAPTPLKMYPSMPA | 101 | P36956 | |
| PLKMYPSMPAFSPGP | 106 | P36956 | |
| NPMPGPMYRVPSFFT | 1036 | Q9C0B9 | |
| MPSAFQYGPTMFVPP | 921 | Q5T6F2 | |
| MGSKSSPPSPYMGFS | 961 | Q70EL4 | |
| MTPGIPIFSPMMPYG | 21 | P20226 | |
| IPGYPKPDMDAMEPS | 2486 | Q6N022 | |
| PVPPGSYMPPSQSYM | 151 | P49750 | |
| MGNMSMPPPFVPYSQ | 511 | P49750 | |
| HSGMMPPIPPAQNFY | 681 | Q9UPT8 | |
| TSMSPDYPNPMFEHP | 2566 | P78527 | |
| SPIFMYAPEFKFMPP | 361 | Q9H3M7 | |
| PPEFYPGPPMMDGAM | 176 | Q969T9 |